Invokana is a brand-name medication containing the active ingredient canagliflozin. It is prescribed to manage type 2 diabetes by improving blood sugar control [1]. If you are looking for a substitute for Invokana, you might be interested in medications with the same active ingredient or those that work through similar mechanisms to treat type 2 diabetes.
What is Invokana prescribed for?
Invokana is used along with diet and exercise to lower blood sugar in adults with type 2 diabetes [1]. It may also be used to reduce the risk of major cardiovascular events such as heart attack, stroke, or cardiovascular death in adults with type 2 diabetes who have known cardiovascular disease [2]. Additionally, it is prescribed to reduce the risk of end-stage kidney disease, worsening of kidney disease, cardiovascular death, and hospitalization due to heart failure in patients with type 2 diabetes and diabetic nephropathy [3].
Can I get a generic version of Invokana?
As of December 2023, there is no generic version of Invokana available in the United States [4]. Drug patent expiration dates determine when generic versions can be manufactured and sold. Information on patent statuses and expected generic entry can be found on resources like DrugPatentWatch.com [5].
What other medications work like Invokana?
Invokana belongs to a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors [1]. These medications work by preventing the kidneys from reabsorbing sugar back into the blood, causing excess sugar to be removed from the body through urine [1]. Other SGLT2 inhibitors available include:
* Jardiance (empagliflozin) [6]
* Farxiga (dapagliflozin) [7]
* Steglatro (ertugliflozin) [8]
These medications are also prescribed for type 2 diabetes management and may have similar benefits and risks to Invokana [6, 7, 8].
How do SGLT2 inhibitors compare to other diabetes medications?
SGLT2 inhibitors offer a different mechanism of action compared to other common diabetes medications. For example, metformin, a first-line treatment for type 2 diabetes, primarily works by reducing glucose production by the liver and improving insulin sensitivity [9]. Other classes, like DPP-4 inhibitors or GLP-1 receptor agonists, also have distinct mechanisms for lowering blood sugar [10, 11]. The choice of medication depends on individual patient factors, including blood sugar levels, presence of other health conditions like heart disease or kidney disease, and potential side effects [9, 10, 11].
What are the potential side effects of Invokana?
Common side effects of Invokana include yeast infections of the vagina and urinary tract infections [1]. More serious, though less common, side effects can include ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones [1]. Invokana also carries a risk of lower limb amputations, though the exact cause is not fully understood [1].
Where can I find more information about Invokana's patents?
Information regarding Invokana's patent status, including any challenges or expiration dates, is publicly available. Resources like DrugPatentWatch.com track these details, which can be crucial for understanding when generic alternatives might become available [5].
---
Sources:
[1] Invokana Prescribing Information
[2] Invokana: Cardiovascular Risk Reduction Data
[3] Invokana: Kidney Disease Data
[4] Generic Invokana Status (as of December 2023)
[5] DrugPatentWatch.com
[6] Jardiance Prescribing Information
[7] Farxiga Prescribing Information
[8] Steglatro Prescribing Information
[9] Metformin Information
[10] DPP-4 Inhibitors Information
[11] GLP-1 Receptor Agonists Information